nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR4—epilepsy syndrome	0.202	0.305	CbGaD
Octreotide—SSTR5—epilepsy syndrome	0.13	0.196	CbGaD
Octreotide—SSTR3—epilepsy syndrome	0.116	0.175	CbGaD
Octreotide—SSTR1—epilepsy syndrome	0.116	0.175	CbGaD
Octreotide—SSTR2—epilepsy syndrome	0.0989	0.149	CbGaD
Octreotide—SSTR5—hindbrain—epilepsy syndrome	0.004	0.0726	CbGeAlD
Octreotide—SSTR3—hindbrain—epilepsy syndrome	0.00383	0.0696	CbGeAlD
Octreotide—SSTR1—hindbrain—epilepsy syndrome	0.00303	0.055	CbGeAlD
Octreotide—SSTR4—forebrain—epilepsy syndrome	0.0026	0.0473	CbGeAlD
Octreotide—SSTR2—hindbrain—epilepsy syndrome	0.00258	0.0468	CbGeAlD
Octreotide—SSTR4—telencephalon—epilepsy syndrome	0.00239	0.0435	CbGeAlD
Octreotide—SSTR5—brainstem—epilepsy syndrome	0.00229	0.0416	CbGeAlD
Octreotide—SSTR3—brainstem—epilepsy syndrome	0.0022	0.0399	CbGeAlD
Octreotide—SSTR1—brainstem—epilepsy syndrome	0.00174	0.0315	CbGeAlD
Octreotide—SSTR1—forebrain—epilepsy syndrome	0.00168	0.0304	CbGeAlD
Octreotide—SSTR1—telencephalon—epilepsy syndrome	0.00154	0.028	CbGeAlD
Octreotide—SSTR4—head—epilepsy syndrome	0.00149	0.0271	CbGeAlD
Octreotide—SSTR2—brainstem—epilepsy syndrome	0.00148	0.0268	CbGeAlD
Octreotide—SSTR2—forebrain—epilepsy syndrome	0.00143	0.0259	CbGeAlD
Octreotide—SSTR4—nervous system—epilepsy syndrome	0.00141	0.0257	CbGeAlD
Octreotide—SSTR4—central nervous system—epilepsy syndrome	0.00136	0.0247	CbGeAlD
Octreotide—SSTR2—telencephalon—epilepsy syndrome	0.00131	0.0238	CbGeAlD
Octreotide—SSTR3—head—epilepsy syndrome	0.00121	0.0221	CbGeAlD
Octreotide—SSTR3—nervous system—epilepsy syndrome	0.00115	0.0209	CbGeAlD
Octreotide—SSTR5—cerebellum—epilepsy syndrome	0.00113	0.0205	CbGeAlD
Octreotide—SSTR3—central nervous system—epilepsy syndrome	0.00111	0.0201	CbGeAlD
Octreotide—SSTR1—midbrain—epilepsy syndrome	0.00111	0.0201	CbGeAlD
Octreotide—SSTR3—cerebellum—epilepsy syndrome	0.00108	0.0197	CbGeAlD
Octreotide—SSTR4—brain—epilepsy syndrome	0.00108	0.0196	CbGeAlD
Octreotide—SSTR1—head—epilepsy syndrome	0.00096	0.0174	CbGeAlD
Octreotide—Pasireotide—SSTR5—epilepsy syndrome	0.000918	0.197	CrCbGaD
Octreotide—SSTR1—nervous system—epilepsy syndrome	0.00091	0.0165	CbGeAlD
Octreotide—SSTR3—brain—epilepsy syndrome	0.00088	0.016	CbGeAlD
Octreotide—SSTR1—central nervous system—epilepsy syndrome	0.000876	0.0159	CbGeAlD
Octreotide—SSTR1—cerebellum—epilepsy syndrome	0.000856	0.0156	CbGeAlD
Octreotide—Pasireotide—SSTR3—epilepsy syndrome	0.000818	0.176	CrCbGaD
Octreotide—Pasireotide—SSTR1—epilepsy syndrome	0.000818	0.176	CrCbGaD
Octreotide—SSTR2—head—epilepsy syndrome	0.000816	0.0148	CbGeAlD
Octreotide—Vapreotide—SSTR5—epilepsy syndrome	0.000781	0.167	CrCbGaD
Octreotide—SSTR2—nervous system—epilepsy syndrome	0.000774	0.0141	CbGeAlD
Octreotide—SSTR2—central nervous system—epilepsy syndrome	0.000745	0.0135	CbGeAlD
Octreotide—SSTR2—cerebellum—epilepsy syndrome	0.000728	0.0132	CbGeAlD
Octreotide—Pasireotide—SSTR2—epilepsy syndrome	0.000696	0.149	CrCbGaD
Octreotide—SSTR1—brain—epilepsy syndrome	0.000696	0.0126	CbGeAlD
Octreotide—Vapreotide—SSTR2—epilepsy syndrome	0.000592	0.127	CrCbGaD
Octreotide—SSTR2—brain—epilepsy syndrome	0.000591	0.0107	CbGeAlD
Octreotide—MPO—forebrain—epilepsy syndrome	0.00054	0.0098	CbGeAlD
Octreotide—MPO—spinal cord—epilepsy syndrome	0.000348	0.00632	CbGeAlD
Octreotide—MPO—head—epilepsy syndrome	0.000309	0.00561	CbGeAlD
Octreotide—MPO—nervous system—epilepsy syndrome	0.000293	0.00532	CbGeAlD
Octreotide—MPO—central nervous system—epilepsy syndrome	0.000282	0.00512	CbGeAlD
Octreotide—MPO—brain—epilepsy syndrome	0.000224	0.00407	CbGeAlD
Octreotide—Desmopressin—PTGS2—epilepsy syndrome	4.02e-05	0.00862	CrCbGaD
Octreotide—Anorexia—Valproic Acid—epilepsy syndrome	2.65e-05	0.000171	CcSEcCtD
Octreotide—Tremor—Gabapentin—epilepsy syndrome	2.64e-05	0.000171	CcSEcCtD
Octreotide—Rash—Diazepam—epilepsy syndrome	2.63e-05	0.000171	CcSEcCtD
Octreotide—Dermatitis—Diazepam—epilepsy syndrome	2.63e-05	0.00017	CcSEcCtD
Octreotide—Visual impairment—Topiramate—epilepsy syndrome	2.63e-05	0.00017	CcSEcCtD
Octreotide—Arthralgia—Pregabalin—epilepsy syndrome	2.62e-05	0.00017	CcSEcCtD
Octreotide—Myalgia—Pregabalin—epilepsy syndrome	2.62e-05	0.00017	CcSEcCtD
Octreotide—Chest pain—Pregabalin—epilepsy syndrome	2.62e-05	0.00017	CcSEcCtD
Octreotide—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.62e-05	0.00017	CcSEcCtD
Octreotide—Dizziness—Zonisamide—epilepsy syndrome	2.62e-05	0.000169	CcSEcCtD
Octreotide—Headache—Diazepam—epilepsy syndrome	2.62e-05	0.000169	CcSEcCtD
Octreotide—Anxiety—Pregabalin—epilepsy syndrome	2.61e-05	0.000169	CcSEcCtD
Octreotide—Diarrhoea—Clonazepam—epilepsy syndrome	2.61e-05	0.000169	CcSEcCtD
Octreotide—Anaemia—Gabapentin—epilepsy syndrome	2.61e-05	0.000169	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.6e-05	0.000168	CcSEcCtD
Octreotide—Asthenia—Carbamazepine—epilepsy syndrome	2.6e-05	0.000168	CcSEcCtD
Octreotide—Agitation—Gabapentin—epilepsy syndrome	2.59e-05	0.000168	CcSEcCtD
Octreotide—Diarrhoea—Phenytoin—epilepsy syndrome	2.59e-05	0.000168	CcSEcCtD
Octreotide—Discomfort—Pregabalin—epilepsy syndrome	2.59e-05	0.000168	CcSEcCtD
Octreotide—Nausea—Fosphenytoin—epilepsy syndrome	2.59e-05	0.000167	CcSEcCtD
Octreotide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.58e-05	0.000167	CcSEcCtD
Octreotide—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.58e-05	0.000167	CcSEcCtD
Octreotide—Vomiting—Felbamate—epilepsy syndrome	2.57e-05	0.000166	CcSEcCtD
Octreotide—Dry mouth—Pregabalin—epilepsy syndrome	2.56e-05	0.000166	CcSEcCtD
Octreotide—Pruritus—Carbamazepine—epilepsy syndrome	2.56e-05	0.000166	CcSEcCtD
Octreotide—Rash—Felbamate—epilepsy syndrome	2.55e-05	0.000165	CcSEcCtD
Octreotide—Dermatitis—Felbamate—epilepsy syndrome	2.55e-05	0.000165	CcSEcCtD
Octreotide—Malaise—Gabapentin—epilepsy syndrome	2.54e-05	0.000165	CcSEcCtD
Octreotide—Tinnitus—Topiramate—epilepsy syndrome	2.54e-05	0.000165	CcSEcCtD
Octreotide—Vertigo—Gabapentin—epilepsy syndrome	2.54e-05	0.000164	CcSEcCtD
Octreotide—Headache—Felbamate—epilepsy syndrome	2.53e-05	0.000164	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.53e-05	0.000164	CcSEcCtD
Octreotide—Cardiac disorder—Topiramate—epilepsy syndrome	2.53e-05	0.000164	CcSEcCtD
Octreotide—Flushing—Topiramate—epilepsy syndrome	2.53e-05	0.000164	CcSEcCtD
Octreotide—Syncope—Gabapentin—epilepsy syndrome	2.53e-05	0.000164	CcSEcCtD
Octreotide—Dizziness—Clonazepam—epilepsy syndrome	2.52e-05	0.000163	CcSEcCtD
Octreotide—Nausea—Vigabatrin—epilepsy syndrome	2.52e-05	0.000163	CcSEcCtD
Octreotide—Vomiting—Zonisamide—epilepsy syndrome	2.52e-05	0.000163	CcSEcCtD
Octreotide—Insomnia—Valproic Acid—epilepsy syndrome	2.51e-05	0.000163	CcSEcCtD
Octreotide—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.51e-05	0.000163	CcSEcCtD
Octreotide—Oedema—Pregabalin—epilepsy syndrome	2.51e-05	0.000163	CcSEcCtD
Octreotide—Asthenia—Lamotrigine—epilepsy syndrome	2.51e-05	0.000162	CcSEcCtD
Octreotide—Dizziness—Phenytoin—epilepsy syndrome	2.51e-05	0.000162	CcSEcCtD
Octreotide—Rash—Zonisamide—epilepsy syndrome	2.5e-05	0.000162	CcSEcCtD
Octreotide—Infection—Pregabalin—epilepsy syndrome	2.5e-05	0.000162	CcSEcCtD
Octreotide—Paraesthesia—Valproic Acid—epilepsy syndrome	2.49e-05	0.000162	CcSEcCtD
Octreotide—Palpitations—Gabapentin—epilepsy syndrome	2.49e-05	0.000161	CcSEcCtD
Octreotide—Dermatitis—Zonisamide—epilepsy syndrome	2.49e-05	0.000161	CcSEcCtD
Octreotide—Dizziness—Oxcarbazepine—epilepsy syndrome	2.49e-05	0.000161	CcSEcCtD
Octreotide—Nausea—Diazepam—epilepsy syndrome	2.48e-05	0.000161	CcSEcCtD
Octreotide—Loss of consciousness—Gabapentin—epilepsy syndrome	2.48e-05	0.000161	CcSEcCtD
Octreotide—Headache—Zonisamide—epilepsy syndrome	2.48e-05	0.000161	CcSEcCtD
Octreotide—Dyspnoea—Valproic Acid—epilepsy syndrome	2.48e-05	0.00016	CcSEcCtD
Octreotide—Diarrhoea—Carbamazepine—epilepsy syndrome	2.48e-05	0.00016	CcSEcCtD
Octreotide—Pruritus—Lamotrigine—epilepsy syndrome	2.47e-05	0.00016	CcSEcCtD
Octreotide—Shock—Pregabalin—epilepsy syndrome	2.47e-05	0.00016	CcSEcCtD
Octreotide—Somnolence—Valproic Acid—epilepsy syndrome	2.47e-05	0.00016	CcSEcCtD
Octreotide—Immune system disorder—Topiramate—epilepsy syndrome	2.46e-05	0.000159	CcSEcCtD
Octreotide—Nervous system disorder—Pregabalin—epilepsy syndrome	2.46e-05	0.000159	CcSEcCtD
Octreotide—Cough—Gabapentin—epilepsy syndrome	2.46e-05	0.000159	CcSEcCtD
Octreotide—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.46e-05	0.000159	CcSEcCtD
Octreotide—Tachycardia—Pregabalin—epilepsy syndrome	2.45e-05	0.000159	CcSEcCtD
Octreotide—Dyspepsia—Valproic Acid—epilepsy syndrome	2.45e-05	0.000158	CcSEcCtD
Octreotide—Convulsion—Gabapentin—epilepsy syndrome	2.45e-05	0.000158	CcSEcCtD
Octreotide—Skin disorder—Pregabalin—epilepsy syndrome	2.44e-05	0.000158	CcSEcCtD
Octreotide—Hypertension—Gabapentin—epilepsy syndrome	2.44e-05	0.000158	CcSEcCtD
Octreotide—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.43e-05	0.000157	CcSEcCtD
Octreotide—Vomiting—Clonazepam—epilepsy syndrome	2.43e-05	0.000157	CcSEcCtD
Octreotide—Decreased appetite—Valproic Acid—epilepsy syndrome	2.42e-05	0.000156	CcSEcCtD
Octreotide—Alopecia—Topiramate—epilepsy syndrome	2.41e-05	0.000156	CcSEcCtD
Octreotide—Vomiting—Phenytoin—epilepsy syndrome	2.41e-05	0.000156	CcSEcCtD
Octreotide—Rash—Clonazepam—epilepsy syndrome	2.41e-05	0.000156	CcSEcCtD
Octreotide—Dermatitis—Clonazepam—epilepsy syndrome	2.4e-05	0.000156	CcSEcCtD
Octreotide—Arthralgia—Gabapentin—epilepsy syndrome	2.4e-05	0.000156	CcSEcCtD
Octreotide—Myalgia—Gabapentin—epilepsy syndrome	2.4e-05	0.000156	CcSEcCtD
Octreotide—Chest pain—Gabapentin—epilepsy syndrome	2.4e-05	0.000156	CcSEcCtD
Octreotide—Nausea—Felbamate—epilepsy syndrome	2.4e-05	0.000156	CcSEcCtD
Octreotide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.4e-05	0.000155	CcSEcCtD
Octreotide—Vomiting—Oxcarbazepine—epilepsy syndrome	2.4e-05	0.000155	CcSEcCtD
Octreotide—Fatigue—Valproic Acid—epilepsy syndrome	2.4e-05	0.000155	CcSEcCtD
Octreotide—Anxiety—Gabapentin—epilepsy syndrome	2.39e-05	0.000155	CcSEcCtD
Octreotide—Anorexia—Pregabalin—epilepsy syndrome	2.39e-05	0.000155	CcSEcCtD
Octreotide—Dizziness—Carbamazepine—epilepsy syndrome	2.39e-05	0.000155	CcSEcCtD
Octreotide—Diarrhoea—Lamotrigine—epilepsy syndrome	2.39e-05	0.000155	CcSEcCtD
Octreotide—Headache—Clonazepam—epilepsy syndrome	2.39e-05	0.000155	CcSEcCtD
Octreotide—Rash—Phenytoin—epilepsy syndrome	2.39e-05	0.000155	CcSEcCtD
Octreotide—Mental disorder—Topiramate—epilepsy syndrome	2.39e-05	0.000155	CcSEcCtD
Octreotide—Dermatitis—Phenytoin—epilepsy syndrome	2.39e-05	0.000155	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.39e-05	0.000154	CcSEcCtD
Octreotide—Rash—Oxcarbazepine—epilepsy syndrome	2.38e-05	0.000154	CcSEcCtD
Octreotide—Constipation—Valproic Acid—epilepsy syndrome	2.38e-05	0.000154	CcSEcCtD
Octreotide—Pain—Valproic Acid—epilepsy syndrome	2.38e-05	0.000154	CcSEcCtD
Octreotide—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.37e-05	0.000154	CcSEcCtD
Octreotide—Headache—Phenytoin—epilepsy syndrome	2.37e-05	0.000154	CcSEcCtD
Octreotide—Erythema—Topiramate—epilepsy syndrome	2.37e-05	0.000154	CcSEcCtD
Octreotide—Malnutrition—Topiramate—epilepsy syndrome	2.37e-05	0.000154	CcSEcCtD
Octreotide—Discomfort—Gabapentin—epilepsy syndrome	2.37e-05	0.000154	CcSEcCtD
Octreotide—Headache—Oxcarbazepine—epilepsy syndrome	2.36e-05	0.000153	CcSEcCtD
Octreotide—Nausea—Zonisamide—epilepsy syndrome	2.35e-05	0.000152	CcSEcCtD
Octreotide—Dry mouth—Gabapentin—epilepsy syndrome	2.35e-05	0.000152	CcSEcCtD
Octreotide—Flatulence—Topiramate—epilepsy syndrome	2.34e-05	0.000151	CcSEcCtD
Octreotide—Tension—Topiramate—epilepsy syndrome	2.33e-05	0.000151	CcSEcCtD
Octreotide—Dizziness—Lamotrigine—epilepsy syndrome	2.31e-05	0.00015	CcSEcCtD
Octreotide—Nervousness—Topiramate—epilepsy syndrome	2.31e-05	0.000149	CcSEcCtD
Octreotide—Oedema—Gabapentin—epilepsy syndrome	2.3e-05	0.000149	CcSEcCtD
Octreotide—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.3e-05	0.000149	CcSEcCtD
Octreotide—Vomiting—Carbamazepine—epilepsy syndrome	2.3e-05	0.000149	CcSEcCtD
Octreotide—Back pain—Topiramate—epilepsy syndrome	2.3e-05	0.000149	CcSEcCtD
Octreotide—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.29e-05	0.000148	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.29e-05	0.000148	CcSEcCtD
Octreotide—Infection—Gabapentin—epilepsy syndrome	2.29e-05	0.000148	CcSEcCtD
Octreotide—Muscle spasms—Topiramate—epilepsy syndrome	2.28e-05	0.000148	CcSEcCtD
Octreotide—Rash—Carbamazepine—epilepsy syndrome	2.28e-05	0.000148	CcSEcCtD
Octreotide—Dermatitis—Carbamazepine—epilepsy syndrome	2.28e-05	0.000148	CcSEcCtD
Octreotide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.27e-05	0.000147	CcSEcCtD
Octreotide—Insomnia—Pregabalin—epilepsy syndrome	2.27e-05	0.000147	CcSEcCtD
Octreotide—Nausea—Clonazepam—epilepsy syndrome	2.27e-05	0.000147	CcSEcCtD
Octreotide—Headache—Carbamazepine—epilepsy syndrome	2.27e-05	0.000147	CcSEcCtD
Octreotide—Shock—Gabapentin—epilepsy syndrome	2.27e-05	0.000147	CcSEcCtD
Octreotide—Nervous system disorder—Gabapentin—epilepsy syndrome	2.26e-05	0.000146	CcSEcCtD
Octreotide—Paraesthesia—Pregabalin—epilepsy syndrome	2.26e-05	0.000146	CcSEcCtD
Octreotide—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.26e-05	0.000146	CcSEcCtD
Octreotide—Nausea—Phenytoin—epilepsy syndrome	2.25e-05	0.000146	CcSEcCtD
Octreotide—Tachycardia—Gabapentin—epilepsy syndrome	2.25e-05	0.000146	CcSEcCtD
Octreotide—Dyspnoea—Pregabalin—epilepsy syndrome	2.24e-05	0.000145	CcSEcCtD
Octreotide—Nausea—Oxcarbazepine—epilepsy syndrome	2.24e-05	0.000145	CcSEcCtD
Octreotide—Vision blurred—Topiramate—epilepsy syndrome	2.24e-05	0.000145	CcSEcCtD
Octreotide—Skin disorder—Gabapentin—epilepsy syndrome	2.24e-05	0.000145	CcSEcCtD
Octreotide—Somnolence—Pregabalin—epilepsy syndrome	2.23e-05	0.000145	CcSEcCtD
Octreotide—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.23e-05	0.000144	CcSEcCtD
Octreotide—Tremor—Topiramate—epilepsy syndrome	2.22e-05	0.000144	CcSEcCtD
Octreotide—Vomiting—Lamotrigine—epilepsy syndrome	2.22e-05	0.000144	CcSEcCtD
Octreotide—Urticaria—Valproic Acid—epilepsy syndrome	2.21e-05	0.000143	CcSEcCtD
Octreotide—Rash—Lamotrigine—epilepsy syndrome	2.2e-05	0.000143	CcSEcCtD
Octreotide—Ill-defined disorder—Topiramate—epilepsy syndrome	2.2e-05	0.000143	CcSEcCtD
Octreotide—Dermatitis—Lamotrigine—epilepsy syndrome	2.2e-05	0.000143	CcSEcCtD
Octreotide—Abdominal pain—Valproic Acid—epilepsy syndrome	2.2e-05	0.000142	CcSEcCtD
Octreotide—Body temperature increased—Valproic Acid—epilepsy syndrome	2.2e-05	0.000142	CcSEcCtD
Octreotide—Anorexia—Gabapentin—epilepsy syndrome	2.2e-05	0.000142	CcSEcCtD
Octreotide—Anaemia—Topiramate—epilepsy syndrome	2.19e-05	0.000142	CcSEcCtD
Octreotide—Headache—Lamotrigine—epilepsy syndrome	2.19e-05	0.000142	CcSEcCtD
Octreotide—Decreased appetite—Pregabalin—epilepsy syndrome	2.18e-05	0.000141	CcSEcCtD
Octreotide—Agitation—Topiramate—epilepsy syndrome	2.18e-05	0.000141	CcSEcCtD
Octreotide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.17e-05	0.00014	CcSEcCtD
Octreotide—Fatigue—Pregabalin—epilepsy syndrome	2.17e-05	0.00014	CcSEcCtD
Octreotide—Nausea—Carbamazepine—epilepsy syndrome	2.15e-05	0.000139	CcSEcCtD
Octreotide—Pain—Pregabalin—epilepsy syndrome	2.15e-05	0.000139	CcSEcCtD
Octreotide—Constipation—Pregabalin—epilepsy syndrome	2.15e-05	0.000139	CcSEcCtD
Octreotide—Malaise—Topiramate—epilepsy syndrome	2.14e-05	0.000139	CcSEcCtD
Octreotide—Vertigo—Topiramate—epilepsy syndrome	2.13e-05	0.000138	CcSEcCtD
Octreotide—Syncope—Topiramate—epilepsy syndrome	2.13e-05	0.000138	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.1e-05	0.000136	CcSEcCtD
Octreotide—Palpitations—Topiramate—epilepsy syndrome	2.1e-05	0.000136	CcSEcCtD
Octreotide—Loss of consciousness—Topiramate—epilepsy syndrome	2.09e-05	0.000135	CcSEcCtD
Octreotide—Insomnia—Gabapentin—epilepsy syndrome	2.08e-05	0.000135	CcSEcCtD
Octreotide—Nausea—Lamotrigine—epilepsy syndrome	2.08e-05	0.000134	CcSEcCtD
Octreotide—Cough—Topiramate—epilepsy syndrome	2.07e-05	0.000134	CcSEcCtD
Octreotide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.07e-05	0.000134	CcSEcCtD
Octreotide—Paraesthesia—Gabapentin—epilepsy syndrome	2.07e-05	0.000134	CcSEcCtD
Octreotide—Convulsion—Topiramate—epilepsy syndrome	2.06e-05	0.000133	CcSEcCtD
Octreotide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.05e-05	0.000133	CcSEcCtD
Octreotide—Dyspnoea—Gabapentin—epilepsy syndrome	2.05e-05	0.000133	CcSEcCtD
Octreotide—Hypertension—Topiramate—epilepsy syndrome	2.05e-05	0.000133	CcSEcCtD
Octreotide—Somnolence—Gabapentin—epilepsy syndrome	2.05e-05	0.000133	CcSEcCtD
Octreotide—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.05e-05	0.000133	CcSEcCtD
Octreotide—Dyspepsia—Gabapentin—epilepsy syndrome	2.03e-05	0.000131	CcSEcCtD
Octreotide—Chest pain—Topiramate—epilepsy syndrome	2.02e-05	0.000131	CcSEcCtD
Octreotide—Arthralgia—Topiramate—epilepsy syndrome	2.02e-05	0.000131	CcSEcCtD
Octreotide—Myalgia—Topiramate—epilepsy syndrome	2.02e-05	0.000131	CcSEcCtD
Octreotide—Anxiety—Topiramate—epilepsy syndrome	2.01e-05	0.00013	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.01e-05	0.00013	CcSEcCtD
Octreotide—Decreased appetite—Gabapentin—epilepsy syndrome	2e-05	0.00013	CcSEcCtD
Octreotide—Discomfort—Topiramate—epilepsy syndrome	2e-05	0.000129	CcSEcCtD
Octreotide—Urticaria—Pregabalin—epilepsy syndrome	2e-05	0.000129	CcSEcCtD
Octreotide—Asthenia—Valproic Acid—epilepsy syndrome	1.99e-05	0.000129	CcSEcCtD
Octreotide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.99e-05	0.000129	CcSEcCtD
Octreotide—Fatigue—Gabapentin—epilepsy syndrome	1.99e-05	0.000129	CcSEcCtD
Octreotide—Body temperature increased—Pregabalin—epilepsy syndrome	1.99e-05	0.000129	CcSEcCtD
Octreotide—Abdominal pain—Pregabalin—epilepsy syndrome	1.99e-05	0.000129	CcSEcCtD
Octreotide—Dry mouth—Topiramate—epilepsy syndrome	1.98e-05	0.000128	CcSEcCtD
Octreotide—Pain—Gabapentin—epilepsy syndrome	1.97e-05	0.000128	CcSEcCtD
Octreotide—Constipation—Gabapentin—epilepsy syndrome	1.97e-05	0.000128	CcSEcCtD
Octreotide—Pruritus—Valproic Acid—epilepsy syndrome	1.97e-05	0.000127	CcSEcCtD
Octreotide—Oedema—Topiramate—epilepsy syndrome	1.94e-05	0.000125	CcSEcCtD
Octreotide—Infection—Topiramate—epilepsy syndrome	1.93e-05	0.000125	CcSEcCtD
Octreotide—Shock—Topiramate—epilepsy syndrome	1.91e-05	0.000123	CcSEcCtD
Octreotide—Diarrhoea—Valproic Acid—epilepsy syndrome	1.9e-05	0.000123	CcSEcCtD
Octreotide—Nervous system disorder—Topiramate—epilepsy syndrome	1.9e-05	0.000123	CcSEcCtD
Octreotide—Feeling abnormal—Gabapentin—epilepsy syndrome	1.9e-05	0.000123	CcSEcCtD
Octreotide—Thrombocytopenia—Topiramate—epilepsy syndrome	1.9e-05	0.000123	CcSEcCtD
Octreotide—Tachycardia—Topiramate—epilepsy syndrome	1.89e-05	0.000122	CcSEcCtD
Octreotide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.88e-05	0.000122	CcSEcCtD
Octreotide—Skin disorder—Topiramate—epilepsy syndrome	1.88e-05	0.000122	CcSEcCtD
Octreotide—Hyperhidrosis—Topiramate—epilepsy syndrome	1.87e-05	0.000121	CcSEcCtD
Octreotide—Hypersensitivity—Pregabalin—epilepsy syndrome	1.85e-05	0.00012	CcSEcCtD
Octreotide—Anorexia—Topiramate—epilepsy syndrome	1.85e-05	0.00012	CcSEcCtD
Octreotide—Dizziness—Valproic Acid—epilepsy syndrome	1.84e-05	0.000119	CcSEcCtD
Octreotide—Urticaria—Gabapentin—epilepsy syndrome	1.83e-05	0.000118	CcSEcCtD
Octreotide—Abdominal pain—Gabapentin—epilepsy syndrome	1.82e-05	0.000118	CcSEcCtD
Octreotide—Body temperature increased—Gabapentin—epilepsy syndrome	1.82e-05	0.000118	CcSEcCtD
Octreotide—Asthenia—Pregabalin—epilepsy syndrome	1.8e-05	0.000117	CcSEcCtD
Octreotide—Pruritus—Pregabalin—epilepsy syndrome	1.78e-05	0.000115	CcSEcCtD
Octreotide—Vomiting—Valproic Acid—epilepsy syndrome	1.77e-05	0.000114	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.77e-05	0.000114	CcSEcCtD
Octreotide—Insomnia—Topiramate—epilepsy syndrome	1.75e-05	0.000113	CcSEcCtD
Octreotide—Rash—Valproic Acid—epilepsy syndrome	1.75e-05	0.000113	CcSEcCtD
Octreotide—Dermatitis—Valproic Acid—epilepsy syndrome	1.75e-05	0.000113	CcSEcCtD
Octreotide—Headache—Valproic Acid—epilepsy syndrome	1.74e-05	0.000113	CcSEcCtD
Octreotide—Paraesthesia—Topiramate—epilepsy syndrome	1.74e-05	0.000113	CcSEcCtD
Octreotide—Dyspnoea—Topiramate—epilepsy syndrome	1.73e-05	0.000112	CcSEcCtD
Octreotide—Somnolence—Topiramate—epilepsy syndrome	1.72e-05	0.000112	CcSEcCtD
Octreotide—Diarrhoea—Pregabalin—epilepsy syndrome	1.72e-05	0.000111	CcSEcCtD
Octreotide—Dyspepsia—Topiramate—epilepsy syndrome	1.71e-05	0.00011	CcSEcCtD
Octreotide—Hypersensitivity—Gabapentin—epilepsy syndrome	1.7e-05	0.00011	CcSEcCtD
Octreotide—Decreased appetite—Topiramate—epilepsy syndrome	1.68e-05	0.000109	CcSEcCtD
Octreotide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.67e-05	0.000108	CcSEcCtD
Octreotide—Fatigue—Topiramate—epilepsy syndrome	1.67e-05	0.000108	CcSEcCtD
Octreotide—Dizziness—Pregabalin—epilepsy syndrome	1.66e-05	0.000108	CcSEcCtD
Octreotide—Pain—Topiramate—epilepsy syndrome	1.66e-05	0.000107	CcSEcCtD
Octreotide—Constipation—Topiramate—epilepsy syndrome	1.66e-05	0.000107	CcSEcCtD
Octreotide—Asthenia—Gabapentin—epilepsy syndrome	1.65e-05	0.000107	CcSEcCtD
Octreotide—Nausea—Valproic Acid—epilepsy syndrome	1.65e-05	0.000107	CcSEcCtD
Octreotide—Pruritus—Gabapentin—epilepsy syndrome	1.63e-05	0.000105	CcSEcCtD
Octreotide—Vomiting—Pregabalin—epilepsy syndrome	1.6e-05	0.000103	CcSEcCtD
Octreotide—Feeling abnormal—Topiramate—epilepsy syndrome	1.6e-05	0.000103	CcSEcCtD
Octreotide—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.58e-05	0.000103	CcSEcCtD
Octreotide—Rash—Pregabalin—epilepsy syndrome	1.58e-05	0.000103	CcSEcCtD
Octreotide—Dermatitis—Pregabalin—epilepsy syndrome	1.58e-05	0.000102	CcSEcCtD
Octreotide—Diarrhoea—Gabapentin—epilepsy syndrome	1.58e-05	0.000102	CcSEcCtD
Octreotide—Headache—Pregabalin—epilepsy syndrome	1.57e-05	0.000102	CcSEcCtD
Octreotide—Urticaria—Topiramate—epilepsy syndrome	1.54e-05	9.97e-05	CcSEcCtD
Octreotide—Body temperature increased—Topiramate—epilepsy syndrome	1.53e-05	9.92e-05	CcSEcCtD
Octreotide—Abdominal pain—Topiramate—epilepsy syndrome	1.53e-05	9.92e-05	CcSEcCtD
Octreotide—Dizziness—Gabapentin—epilepsy syndrome	1.52e-05	9.86e-05	CcSEcCtD
Octreotide—Nausea—Pregabalin—epilepsy syndrome	1.49e-05	9.66e-05	CcSEcCtD
Octreotide—Vomiting—Gabapentin—epilepsy syndrome	1.46e-05	9.48e-05	CcSEcCtD
Octreotide—Rash—Gabapentin—epilepsy syndrome	1.45e-05	9.4e-05	CcSEcCtD
Octreotide—Dermatitis—Gabapentin—epilepsy syndrome	1.45e-05	9.39e-05	CcSEcCtD
Octreotide—Headache—Gabapentin—epilepsy syndrome	1.44e-05	9.34e-05	CcSEcCtD
Octreotide—Hypersensitivity—Topiramate—epilepsy syndrome	1.43e-05	9.24e-05	CcSEcCtD
Octreotide—Asthenia—Topiramate—epilepsy syndrome	1.39e-05	9e-05	CcSEcCtD
Octreotide—Pruritus—Topiramate—epilepsy syndrome	1.37e-05	8.88e-05	CcSEcCtD
Octreotide—Nausea—Gabapentin—epilepsy syndrome	1.37e-05	8.86e-05	CcSEcCtD
Octreotide—Diarrhoea—Topiramate—epilepsy syndrome	1.33e-05	8.58e-05	CcSEcCtD
Octreotide—Dizziness—Topiramate—epilepsy syndrome	1.28e-05	8.3e-05	CcSEcCtD
Octreotide—Vomiting—Topiramate—epilepsy syndrome	1.23e-05	7.98e-05	CcSEcCtD
Octreotide—Rash—Topiramate—epilepsy syndrome	1.22e-05	7.91e-05	CcSEcCtD
Octreotide—Dermatitis—Topiramate—epilepsy syndrome	1.22e-05	7.9e-05	CcSEcCtD
Octreotide—Headache—Topiramate—epilepsy syndrome	1.21e-05	7.86e-05	CcSEcCtD
Octreotide—Nausea—Topiramate—epilepsy syndrome	1.15e-05	7.45e-05	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—AGT—epilepsy syndrome	1.13e-05	9.33e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HES1—epilepsy syndrome	1.13e-05	9.31e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.13e-05	9.28e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HSPB1—epilepsy syndrome	1.12e-05	9.25e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL3—epilepsy syndrome	1.12e-05	9.25e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL2—epilepsy syndrome	1.12e-05	9.25e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BDKRB2—epilepsy syndrome	1.12e-05	9.25e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—OXT—epilepsy syndrome	1.12e-05	9.25e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CRH—epilepsy syndrome	1.12e-05	9.25e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL12—epilepsy syndrome	1.12e-05	9.25e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—POMC—epilepsy syndrome	1.12e-05	9.24e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.12e-05	9.23e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PRKCB—epilepsy syndrome	1.12e-05	9.21e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PLAT—epilepsy syndrome	1.12e-05	9.19e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6ST—epilepsy syndrome	1.11e-05	9.17e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCR5—epilepsy syndrome	1.11e-05	9.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR3—epilepsy syndrome	1.1e-05	9.08e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JUNB—epilepsy syndrome	1.1e-05	9.08e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CNR1—epilepsy syndrome	1.1e-05	9.08e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.1e-05	9.08e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PLCB1—epilepsy syndrome	1.1e-05	9.05e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FYN—epilepsy syndrome	1.1e-05	9.05e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—H2AFX—epilepsy syndrome	1.1e-05	9.02e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MEF2C—epilepsy syndrome	1.09e-05	9e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HTR2A—epilepsy syndrome	1.09e-05	8.93e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.08e-05	8.87e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.08e-05	8.87e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HTR7—epilepsy syndrome	1.08e-05	8.86e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—POMC—epilepsy syndrome	1.08e-05	8.86e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.08e-05	8.85e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NPY—epilepsy syndrome	1.08e-05	8.85e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.07e-05	8.83e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.07e-05	8.8e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JUNB—epilepsy syndrome	1.06e-05	8.71e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CNR1—epilepsy syndrome	1.06e-05	8.71e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—YWHAZ—epilepsy syndrome	1.06e-05	8.7e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.05e-05	8.68e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.05e-05	8.62e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AGT—epilepsy syndrome	1.05e-05	8.61e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TSC1—epilepsy syndrome	1.04e-05	8.6e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NGF—epilepsy syndrome	1.04e-05	8.6e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HBEGF—epilepsy syndrome	1.04e-05	8.6e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTK2B—epilepsy syndrome	1.04e-05	8.6e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HSPB1—epilepsy syndrome	1.04e-05	8.54e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL3—epilepsy syndrome	1.04e-05	8.54e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL2—epilepsy syndrome	1.04e-05	8.54e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CRH—epilepsy syndrome	1.04e-05	8.54e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—OXT—epilepsy syndrome	1.04e-05	8.54e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HTR7—epilepsy syndrome	1.03e-05	8.5e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AGT—epilepsy syndrome	1.03e-05	8.48e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT3—epilepsy syndrome	1.03e-05	8.44e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCR5—epilepsy syndrome	1.02e-05	8.42e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—POMC—epilepsy syndrome	1.02e-05	8.39e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCR2—epilepsy syndrome	1.02e-05	8.37e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NTRK2—epilepsy syndrome	1.02e-05	8.37e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SST—epilepsy syndrome	1.02e-05	8.37e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCR5—epilepsy syndrome	1.02e-05	8.37e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—DUSP6—epilepsy syndrome	1.01e-05	8.29e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HBEGF—epilepsy syndrome	1e-05	8.25e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ADAM10—epilepsy syndrome	1e-05	8.25e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HTR2A—epilepsy syndrome	1e-05	8.24e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCL2—epilepsy syndrome	9.97e-06	8.21e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADRA2A—epilepsy syndrome	9.95e-06	8.19e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HTR2A—epilepsy syndrome	9.95e-06	8.19e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PLAT—epilepsy syndrome	9.91e-06	8.15e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT3—epilepsy syndrome	9.83e-06	8.1e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—POMC—epilepsy syndrome	9.77e-06	8.04e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.67e-06	7.96e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TSC1—epilepsy syndrome	9.64e-06	7.94e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTK2B—epilepsy syndrome	9.64e-06	7.94e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ADAM10—epilepsy syndrome	9.6e-06	7.91e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCL2—epilepsy syndrome	9.56e-06	7.87e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BDKRB2—epilepsy syndrome	9.56e-06	7.87e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL12—epilepsy syndrome	9.56e-06	7.87e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—POMC—epilepsy syndrome	9.54e-06	7.86e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PRKCB—epilepsy syndrome	9.51e-06	7.83e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AGT—epilepsy syndrome	9.5e-06	7.82e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6ST—epilepsy syndrome	9.47e-06	7.8e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—S100B—epilepsy syndrome	9.47e-06	7.8e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TSC2—epilepsy syndrome	9.45e-06	7.78e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AGT—epilepsy syndrome	9.44e-06	7.77e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR2—epilepsy syndrome	9.38e-06	7.72e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—JUNB—epilepsy syndrome	9.38e-06	7.72e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NTRK2—epilepsy syndrome	9.38e-06	7.72e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SST—epilepsy syndrome	9.38e-06	7.72e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SOCS3—epilepsy syndrome	9.38e-06	7.72e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CNR1—epilepsy syndrome	9.38e-06	7.72e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDC42—epilepsy syndrome	9.36e-06	7.7e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PLCB1—epilepsy syndrome	9.35e-06	7.69e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—DUSP6—epilepsy syndrome	9.3e-06	7.66e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APOE—epilepsy syndrome	9.25e-06	7.61e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADRA2A—epilepsy syndrome	9.18e-06	7.56e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HTR7—epilepsy syndrome	9.15e-06	7.53e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PLAT—epilepsy syndrome	9.14e-06	7.53e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—S100B—epilepsy syndrome	9.08e-06	7.48e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KDR—epilepsy syndrome	9.06e-06	7.46e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AVP—epilepsy syndrome	9.06e-06	7.46e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SOCS3—epilepsy syndrome	8.99e-06	7.4e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDC42—epilepsy syndrome	8.97e-06	7.39e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HBEGF—epilepsy syndrome	8.88e-06	7.31e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL12—epilepsy syndrome	8.82e-06	7.26e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BDKRB2—epilepsy syndrome	8.82e-06	7.26e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—POMC—epilepsy syndrome	8.81e-06	7.25e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PRKCB—epilepsy syndrome	8.78e-06	7.23e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6ST—epilepsy syndrome	8.74e-06	7.2e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PRKCB—epilepsy syndrome	8.72e-06	7.18e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT3—epilepsy syndrome	8.72e-06	7.18e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AVP—epilepsy syndrome	8.69e-06	7.15e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6ST—epilepsy syndrome	8.69e-06	7.15e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—POMC—epilepsy syndrome	8.67e-06	7.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JUNB—epilepsy syndrome	8.66e-06	7.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CNR1—epilepsy syndrome	8.66e-06	7.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PLCB1—epilepsy syndrome	8.63e-06	7.1e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HES1—epilepsy syndrome	8.57e-06	7.05e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADAM10—epilepsy syndrome	8.52e-06	7.01e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCL2—epilepsy syndrome	8.48e-06	6.98e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HTR7—epilepsy syndrome	8.45e-06	6.95e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FYN—epilepsy syndrome	8.33e-06	6.86e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—H2AFX—epilepsy syndrome	8.3e-06	6.83e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MEF2C—epilepsy syndrome	8.29e-06	6.82e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HES1—epilepsy syndrome	8.21e-06	6.76e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HBEGF—epilepsy syndrome	8.2e-06	6.75e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—S100B—epilepsy syndrome	8.05e-06	6.63e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT3—epilepsy syndrome	8.05e-06	6.63e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—YWHAZ—epilepsy syndrome	8.01e-06	6.59e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—POMC—epilepsy syndrome	8e-06	6.58e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FYN—epilepsy syndrome	7.99e-06	6.58e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SOCS3—epilepsy syndrome	7.98e-06	6.57e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—H2AFX—epilepsy syndrome	7.96e-06	6.55e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDC42—epilepsy syndrome	7.96e-06	6.55e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—POMC—epilepsy syndrome	7.94e-06	6.54e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MEF2C—epilepsy syndrome	7.94e-06	6.54e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NGF—epilepsy syndrome	7.92e-06	6.52e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADAM10—epilepsy syndrome	7.86e-06	6.47e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCL2—epilepsy syndrome	7.82e-06	6.44e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL2—epilepsy syndrome	7.77e-06	6.4e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AVP—epilepsy syndrome	7.7e-06	6.34e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCR5—epilepsy syndrome	7.7e-06	6.34e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.68e-06	6.32e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NGF—epilepsy syndrome	7.59e-06	6.25e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HTR2A—epilepsy syndrome	7.54e-06	6.21e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—S100B—epilepsy syndrome	7.43e-06	6.12e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCR5—epilepsy syndrome	7.39e-06	6.08e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SOCS3—epilepsy syndrome	7.36e-06	6.06e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDC42—epilepsy syndrome	7.34e-06	6.05e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HES1—epilepsy syndrome	7.28e-06	6e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HTR2A—epilepsy syndrome	7.23e-06	5.95e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TSC2—epilepsy syndrome	7.16e-06	5.9e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGT—epilepsy syndrome	7.15e-06	5.89e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AVP—epilepsy syndrome	7.11e-06	5.85e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FYN—epilepsy syndrome	7.08e-06	5.83e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—H2AFX—epilepsy syndrome	7.06e-06	5.81e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MEF2C—epilepsy syndrome	7.05e-06	5.8e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FGF2—epilepsy syndrome	7.02e-06	5.78e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOE—epilepsy syndrome	7.01e-06	5.77e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TSC2—epilepsy syndrome	6.87e-06	5.65e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KDR—epilepsy syndrome	6.87e-06	5.65e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGT—epilepsy syndrome	6.86e-06	5.65e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—YWHAZ—epilepsy syndrome	6.81e-06	5.61e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NGF—epilepsy syndrome	6.73e-06	5.54e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HES1—epilepsy syndrome	6.72e-06	5.53e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOE—epilepsy syndrome	6.72e-06	5.53e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PRKCB—epilepsy syndrome	6.61e-06	5.44e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KDR—epilepsy syndrome	6.58e-06	5.42e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6ST—epilepsy syndrome	6.58e-06	5.42e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCR5—epilepsy syndrome	6.55e-06	5.39e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FYN—epilepsy syndrome	6.54e-06	5.38e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RELA—epilepsy syndrome	6.52e-06	5.37e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—H2AFX—epilepsy syndrome	6.51e-06	5.36e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MEF2C—epilepsy syndrome	6.5e-06	5.35e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HTR2A—epilepsy syndrome	6.41e-06	5.28e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MTOR—epilepsy syndrome	6.39e-06	5.26e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PRKCB—epilepsy syndrome	6.34e-06	5.22e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6ST—epilepsy syndrome	6.31e-06	5.2e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.28e-06	5.17e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NGF—epilepsy syndrome	6.21e-06	5.12e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TSC2—epilepsy syndrome	6.09e-06	5.01e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGT—epilepsy syndrome	6.08e-06	5.01e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR5—epilepsy syndrome	6.04e-06	4.98e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—POMC—epilepsy syndrome	6.02e-06	4.96e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOE—epilepsy syndrome	5.96e-06	4.91e-05	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—epilepsy syndrome	5.94e-06	4.89e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HTR2A—epilepsy syndrome	5.92e-06	4.87e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL2—epilepsy syndrome	5.89e-06	4.85e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—epilepsy syndrome	5.88e-06	4.84e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KDR—epilepsy syndrome	5.84e-06	4.81e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—POMC—epilepsy syndrome	5.77e-06	4.75e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—JUN—epilepsy syndrome	5.71e-06	4.7e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL2—epilepsy syndrome	5.65e-06	4.65e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TSC2—epilepsy syndrome	5.62e-06	4.63e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PRKCB—epilepsy syndrome	5.62e-06	4.63e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGT—epilepsy syndrome	5.61e-06	4.62e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6ST—epilepsy syndrome	5.6e-06	4.61e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—epilepsy syndrome	5.56e-06	4.58e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOE—epilepsy syndrome	5.5e-06	4.53e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—epilepsy syndrome	5.39e-06	4.44e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—epilepsy syndrome	5.39e-06	4.44e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FGF2—epilepsy syndrome	5.32e-06	4.38e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRKCB—epilepsy syndrome	5.19e-06	4.27e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6ST—epilepsy syndrome	5.17e-06	4.25e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SRC—epilepsy syndrome	5.12e-06	4.22e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—POMC—epilepsy syndrome	5.12e-06	4.21e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FGF2—epilepsy syndrome	5.1e-06	4.2e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL2—epilepsy syndrome	5.01e-06	4.12e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—epilepsy syndrome	4.99e-06	4.11e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RELA—epilepsy syndrome	4.94e-06	4.07e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MTOR—epilepsy syndrome	4.85e-06	3.99e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RELA—epilepsy syndrome	4.74e-06	3.9e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—POMC—epilepsy syndrome	4.72e-06	3.89e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MTOR—epilepsy syndrome	4.65e-06	3.83e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL2—epilepsy syndrome	4.62e-06	3.81e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGF2—epilepsy syndrome	4.53e-06	3.73e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—epilepsy syndrome	4.5e-06	3.7e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—epilepsy syndrome	4.46e-06	3.67e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JUN—epilepsy syndrome	4.33e-06	3.56e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.31e-06	3.55e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—epilepsy syndrome	4.27e-06	3.52e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—epilepsy syndrome	4.21e-06	3.47e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RELA—epilepsy syndrome	4.2e-06	3.46e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGF2—epilepsy syndrome	4.18e-06	3.44e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JUN—epilepsy syndrome	4.15e-06	3.42e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MTOR—epilepsy syndrome	4.12e-06	3.39e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—epilepsy syndrome	4.09e-06	3.36e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—epilepsy syndrome	4.04e-06	3.32e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—epilepsy syndrome	3.92e-06	3.22e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SRC—epilepsy syndrome	3.88e-06	3.2e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RELA—epilepsy syndrome	3.88e-06	3.19e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—epilepsy syndrome	3.83e-06	3.15e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MTOR—epilepsy syndrome	3.8e-06	3.13e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—epilepsy syndrome	3.79e-06	3.12e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—epilepsy syndrome	3.78e-06	3.11e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SRC—epilepsy syndrome	3.72e-06	3.07e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—JUN—epilepsy syndrome	3.68e-06	3.03e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—epilepsy syndrome	3.63e-06	2.99e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—epilepsy syndrome	3.58e-06	2.95e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.53e-06	2.91e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—epilepsy syndrome	3.5e-06	2.88e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—epilepsy syndrome	3.47e-06	2.86e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JUN—epilepsy syndrome	3.4e-06	2.8e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—epilepsy syndrome	3.31e-06	2.72e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SRC—epilepsy syndrome	3.3e-06	2.72e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—epilepsy syndrome	3.22e-06	2.65e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—epilepsy syndrome	3.21e-06	2.64e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—epilepsy syndrome	3.18e-06	2.62e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SRC—epilepsy syndrome	3.05e-06	2.51e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—epilepsy syndrome	2.97e-06	2.44e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—epilepsy syndrome	2.41e-06	1.99e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—epilepsy syndrome	2.31e-06	1.9e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—epilepsy syndrome	2.05e-06	1.69e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—epilepsy syndrome	1.89e-06	1.56e-05	CbGpPWpGaD
